Stifel Financial’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $61.4K | Hold |
48,000
| – | – | ﹤0.01% | 3403 |
|
2025
Q1 | $48K | Hold |
48,000
| – | – | ﹤0.01% | 3357 |
|
2024
Q4 | $43.7K | Buy |
48,000
+3,000
| +7% | +$2.73K | ﹤0.01% | 3322 |
|
2024
Q3 | $67.5K | Hold |
45,000
| – | – | ﹤0.01% | 3286 |
|
2024
Q2 | $31.6K | Hold |
45,000
| – | – | ﹤0.01% | 3307 |
|
2024
Q1 | $42.8K | Hold |
45,000
| – | – | ﹤0.01% | 3265 |
|
2023
Q4 | $50K | Buy |
+45,000
| New | +$50K | ﹤0.01% | 3227 |
|
2022
Q2 | – | Sell |
-13,585
| Closed | -$43K | – | 3347 |
|
2022
Q1 | $43K | Hold |
13,585
| – | – | ﹤0.01% | 3318 |
|
2021
Q4 | $57K | Sell |
13,585
-10,040
| -42% | -$42.1K | ﹤0.01% | 3302 |
|
2021
Q3 | $192K | Hold |
23,625
| – | – | ﹤0.01% | 3144 |
|
2021
Q2 | $178K | Hold |
23,625
| – | – | ﹤0.01% | 3154 |
|
2021
Q1 | $205K | Buy |
23,625
+6,800
| +40% | +$59K | ﹤0.01% | 3006 |
|
2020
Q4 | $134K | Hold |
16,825
| – | – | ﹤0.01% | 2907 |
|
2020
Q3 | $134K | Hold |
16,825
| – | – | ﹤0.01% | 2709 |
|
2020
Q2 | $167K | Buy |
+16,825
| New | +$167K | ﹤0.01% | 2626 |
|